Cross-fund · 4 holders
SPRO
SPERO THERAPEUTICS INC
CUSIP 84833T103
4
Tracked holders
$7.0M
Aggregate value
3,001,990
Shares
5
Active funds
Funds holding SPRO
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $4.9M | — | +93,607 | +4.7% |
| BlackRock | Institutional | Q1 2026 | $1.0M | — | −414 | −0.1% |
| Citadel | Multi-Strategy | Q1 2026 | $996,040 | — | −45,306 | −9.6% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $139,623 | — | +16,089 | +36.9% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | −24,107 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.